(Downloading may take up to 30 seconds.
If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.



Fig. 4. Repression of Bmp4-signaling pathways requires high doses of Pitx2. (A-G) Whole-mount in situ analysis of 10.5 dpc Pitx2 {delta}abcnull homozygous mutant (A), Pitx2 wild-type (B,E), {delta}abcnull; {delta}abhypoc (C,F) {delta}abcnull; {delta}ab (D,G) embryos with a Bmp4 probe. (H-K) Whole-mount in situ analysis of 10.5 dpc Pitx2 wild-type (H), {delta}abcnull homozygous mutant (I), {delta}abcnull; {delta}abhypoc (J) and {delta}abcnull; {delta}ab (K) embryos with Msx2. (L-O) Whole-mount in situ of 10.5 dpc wild-type (L), Pitx2 {delta}abcnull homozygous mutant (M), {delta}abcnull; {delta}abhypoc (N) and {delta}abcnull; {delta}ab (O) embryos with Msx1 showing normal (arrows) and expanded (arrowheads) areas of expression. *Areas in wild type with expanded expression in mutant. md, mandibular process; mx maxillary process.